HELPDESK ANSWERSIn postmenopausal women diagnosed with breast cancer, is an aromatase inhibitor or estrogen receptor modulator associated with better outcomes?Wilson, Lynn Marie MD; Albakoaa, Faris MD; Hansen, Susan E MA Author Information Lehigh Valley Health Network, Allentown, PA The corresponding author is Lynn Marie Wilson; [email protected] The authors declare no conflict of interest. Evidence-Based Practice 26(2):p 31-33, February 2023. | DOI: 10.1097/EBP.0000000000001747 Buy Metrics Copyright © 2022 by Family Physicians Inquiries Network, Inc.
